These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 28206770
21. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers. Huang J, Li Y, Wigent RJ, Malick WA, Sandhu HK, Singhal D, Shah NH. Int J Pharm; 2011 Nov 25; 420(1):59-67. PubMed ID: 21871546 [Abstract] [Full Text] [Related]
22. Modified release of coated sugar spheres using drug-containing polymeric dispersions. Kim TW, Ji CW, Shim SY, Lee BJ. Arch Pharm Res; 2007 Jan 25; 30(1):124-30. PubMed ID: 17328252 [Abstract] [Full Text] [Related]
23. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets. Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z. Int J Pharm; 2012 Apr 15; 426(1-2):21-28. PubMed ID: 22266529 [Abstract] [Full Text] [Related]
24. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Serratoni M, Newton M, Booth S, Clarke A. Eur J Pharm Biopharm; 2007 Jan 15; 65(1):94-8. PubMed ID: 17056237 [Abstract] [Full Text] [Related]
25. Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels. Lugtu-Pe JA, Lin BY, Chen K, Ghaffari A, Kane A, Wu XY. Mol Pharm; 2021 Nov 01; 18(11):4198-4209. PubMed ID: 34668379 [Abstract] [Full Text] [Related]
26. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D, Zheng W, Coots LB, McGinity JW. Eur J Pharm Biopharm; 2007 Sep 01; 67(2):464-75. PubMed ID: 17451929 [Abstract] [Full Text] [Related]
27. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. Int J Pharm; 2007 May 04; 336(1):22-34. PubMed ID: 17174493 [Abstract] [Full Text] [Related]
28. Development of extended release dosage forms using non-uniform drug distribution techniques. Huang KK, Wang DP, Meng CL. Drug Dev Ind Pharm; 2002 May 04; 28(5):593-9. PubMed ID: 12098848 [Abstract] [Full Text] [Related]
29. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ. Doreth M, Hussein MA, Priemel PA, Grohganz H, Holm R, Lopez de Diego H, Rades T, Löbmann K. Int J Pharm; 2017 Mar 15; 519(1-2):343-351. PubMed ID: 28115260 [Abstract] [Full Text] [Related]
30. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H. J Pharm Sci; 2008 Jun 15; 97(6):2286-98. PubMed ID: 17879977 [Abstract] [Full Text] [Related]
31. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers. Barbosa JAC, Al-Kauraishi MM, Smith AM, Conway BR, Merchant HA. Eur J Pharm Biopharm; 2019 Nov 15; 144():174-179. PubMed ID: 31541663 [Abstract] [Full Text] [Related]
32. Ethanol-resistant ethylcellulose/guar gum coatings--importance of formulation parameters. Rosiaux Y, Velghe C, Muschert S, Chokshi R, Leclercq B, Siepmann F, Siepmann J. Eur J Pharm Biopharm; 2013 Nov 15; 85(3 Pt B):1250-8. PubMed ID: 23891769 [Abstract] [Full Text] [Related]
33. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C. Eur J Pharm Biopharm; 2008 Sep 15; 70(1):302-12. PubMed ID: 18579353 [Abstract] [Full Text] [Related]
34. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H. J Pharm Sci; 2005 Nov 15; 94(11):2463-74. PubMed ID: 16200544 [Abstract] [Full Text] [Related]
35. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Karavas E, Georgarakis E, Bikiaris D. Eur J Pharm Biopharm; 2006 Aug 15; 64(1):115-26. PubMed ID: 16675210 [Abstract] [Full Text] [Related]
36. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution. Prasad D, Chauhan H, Atef E. Mol Pharm; 2016 Mar 07; 13(3):756-65. PubMed ID: 26866895 [Abstract] [Full Text] [Related]
37. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters. Riekes MK, Dereymaker A, Berben P, Augustijns P, Stulzer HK, Van den Mooter G. Int J Pharm; 2017 Mar 30; 520(1-2):49-58. PubMed ID: 28153650 [Abstract] [Full Text] [Related]
38. Applying a novel electrostatic dry powder coating technology to pellets. Yang Q, Ma Y, Zhu J. Eur J Pharm Biopharm; 2015 Nov 30; 97(Pt A):118-24. PubMed ID: 26478275 [Abstract] [Full Text] [Related]
39. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles. Bussemer T, Bodmeier R. Int J Pharm; 2003 Nov 28; 267(1-2):59-68. PubMed ID: 14602384 [Abstract] [Full Text] [Related]
40. Evaluating the effect of coating equipment on tablet film quality using terahertz pulsed imaging. Haaser M, Naelapää K, Gordon KC, Pepper M, Rantanen J, Strachan CJ, Taday PF, Zeitler JA, Rades T. Eur J Pharm Biopharm; 2013 Nov 28; 85(3 Pt B):1095-102. PubMed ID: 23563103 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]